Skip to main content

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome: Results of a Randomized Comparative Phase III Study

Publication ,  Conference
Cortes, J; Seiter, K; Maziarz, RT; Wetzler, M; Craig, M; Matous, J; Luger, S; Dey, B; Schiller, GJ; Pham, D; Abboud, CN; Krishnamurthy, M ...
Published in: BLOOD
November 16, 2008

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2008

Volume

112

Issue

11

Start / End Page

340 / 341

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

50th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cortes, J., Seiter, K., Maziarz, R. T., Wetzler, M., Craig, M., Matous, J., … Moore, J. O. (2008). Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome: Results of a Randomized Comparative Phase III Study. In BLOOD (Vol. 112, pp. 340–341). San Francisco, CA: AMER SOC HEMATOLOGY.
Cortes, Jorge, Karen Seiter, Richard Thomas Maziarz, Meir Wetzler, Michael Craig, Jeffrey Matous, Selina Luger, et al. “Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome: Results of a Randomized Comparative Phase III Study.” In BLOOD, 112:340–41. AMER SOC HEMATOLOGY, 2008.
Cortes J, Seiter K, Maziarz RT, Wetzler M, Craig M, Matous J, Luger S, Dey B, Schiller GJ, Pham D, Abboud CN, Krishnamurthy M, Brown A, Moore JO. Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome: Results of a Randomized Comparative Phase III Study. BLOOD. AMER SOC HEMATOLOGY; 2008. p. 340–341.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2008

Volume

112

Issue

11

Start / End Page

340 / 341

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

50th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology